IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8003-8010

  Janas, Michelle L ^a,b   Groves, Penny ^a   Kienzle, Norbert ^a   Kelso, Anne ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; COMPLEMENTARY DNA; GRANZYME A; GRANZYME B; GRANZYME C; INTERLEUKIN 2; MESSENGER RNA; PERFORIN; PROTEIN BCL 2; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; EFFECTOR CELL; FEMALE; GENE EXPRESSION REGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 29144498235     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8003     Document Type: Article

References (59)

1. Lieberman, J. 2003. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3: 361-370.
2. Podack, E. R., J. D. Young, and Z. A. Cohn. 1985. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 82: 8629-8633.
3. Pinkoski, M. J., M. Hobman, J. A. Heibein, K. Tomaselli, F. Li, P. Seth, C. J. Froelich, and R. C. Bleackley. 1998. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood 92: 1044-1054.
4. Metkar, S. S., B. Wang, M. Aguilar-Santelises, S. M. Raja, L. Uhlin-Hansen, E. Podack, J. A. Trapani, and C. J. Froelich. 2002. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16: 417-428.
5. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
6. Darmon, A. J., D. W. Nicholson, and R. C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446-448.
7. Heibein, J. A., I. S. Goping, M. Barry, M. J. Pinkoski, G. C. Shore, D. R. Green, and R. C. Bleackley. 2000. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med. 192: 1391-1402.
8. Lieberman, J., and Z. Fan. 2003. Nuclear war: the granzyme A-bomb. Curr. Opin. Immunol. 15: 553-559.
9. Ebnet, K., M. Hausmann, F. Lehmann-Grube, A. Mullbacher, M. Kopf, M. Lamers, and M. M. Simon. 1995. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 14: 4230-4239.
10. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987.
11. Müllbacher, A., P. Waring, R. Tha Hla, T. Tran, S. Chin, T. Stehle, C. Museteanu, and M. M. Simon. 1999. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 96: 13950-13955.
12. Johnson, H., L. Scorrano, S. J. Korsmeyer, and T. J. Ley. 2003. Cell death induced by granzyme C. Blood 101: 3093-3101.
13. + T cells during primary activation. Int. Immunol. 14: 605-613.
14. Grossman, W. J., P. A. Revell, Z. H. Lu, H. Johnson, A. J. Bredemeyer, and T. J. Ley. 2003. The orphan granzymes of humans and mice. Curr. Opin. Immunol. 15: 544-552.
15. Garcia-Sanz, J. A., H. R. MacDonald, D. E. Jenne, J. Tschopp, and M. Nabholz. 1990. Cell specificity of granzyme gene expression. J. Immunol. 145: 3111-3118.
16. Liu, C. C., S. Rafii, A. Granelli-Piperno, J. A. Trapani, and J. D. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells: kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170: 2105-2118.
17. Yu, C. R., J. R. Ortaldo, R. E. Curiel, H. A. Young, S. K. Anderson, and P. Gosselin. 1999. Role of a STAT binding site in the regulation of the human perforin promoter. J. Immunol. 162: 2785-2790.
18. Zhang, J., I. Scordi, M. J. Smyth, and M. G. Lichtenheld. 1999. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J. Exp. Med. 190: 1297-1308.
19. Farrar, W., H. Johnson, and J. Farrar. 1981. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J. Immunol. 126: 1120-1125.
20. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1007-1008.
21. Miyazaki, T., Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Permutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231.
22. Gaffen, S. L. 2001. Signaling domains of the interleukin 2 receptor. Cytokine 14: 63-77.
23. + T cell homeostasis. J. Immunol. 170: 210-217.
24. Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10: 249-259.
25. Strasser, A., A. W. Harris, D. L. Vaux, E. Webb, M. L. Bath, J. M. Adams, and S. Cory. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166: 175-181.
26. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
27. + T cells and induces synthesis of IL-3 and IFN-γ but not IL-4 or IL-6. Int. Immunol. 4: 475-485.
28. Fitzpatrick, D. R., and A. Kelso. 1995. Dissociated expression of granulocyte-macrophage CSF and IL-3 in short-term T cell clones from normal mice. J. Immunol. 155: 5140-5150.
29. + T cells. J. Immunol. 148: 3354-3360.
30. Arad, G., R. Nussinovich, and R. Kaempfer. 1995. Interleukin-2 induces an early step in the activation of interferon-γ gene expression. Immunol. Lett. 44: 213-216.
31. Otani, H., M. Erdos, and W. J. Leonard. 1993. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem. 268: 22733-22736.
32. S) gene expression. Eur. J. Immunol. 26: 294-299.
33. Strasser, A., A. W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899.
34. Heckford, S. E., E. P. Gelmann, C. L. Agnor, S. Jacobson, S. Zinn, and L. A. Matis. 1986. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones. J. Immunol. 137: 3652-3663.
35. Gett, A. V., and P. D. Hodgkin. 1998. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA 95: 9488-9493.
36. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, M. A. Mahowald, J. R. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9: 229-237.
37. Lin, J. X., and W. J. Leonard. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19: 2566-2576.
38. Bream, J. H., D. L. Hodge, T. Gonsky, R. Spolski, W. J. Leonard, S. Krebs, S. Targan, A. Morinobu, J. J. O'Shea, and H. A. Young. 2004. A distal region in the interferon-γ gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2. J. Biol. Chem. 279: 41249-41257.
39. Zhou, J., J. Zhang, M. G. Lichtenheld, and G. G. Meadows. 2002. A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling. J. Immunol. 169: 1319-1325.
40. Wargnier, A., S. Legros-Maida, R. Bosselut, J. F. Bourge, C. Lafaurie, C. J. Ghysdael, M. Sasportes, and P. Paul. 1995. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc. Natl. Acad. Sci. USA 92: 6930-6934.
41. Babichuk, C. K., B. L. Duggan, and R. C. Bleackley. 1996. In vivo regulation of murine granzyme B gene transcription in activated primary T cells. J. Biol. Chem. 271: 16485-16493.
42. + T cell function by the transcription factor eomesodermin. Science 302: 1041-1043.
43. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262: 1059-1061.
44. Steiger, J., P. W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T. B. Strom. 1995. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155: 489-498.
45. Kramer, S., C. Mamalaki, I. Horak, A. Schimpl, D. Kioussis, and T. Hung. 1994. Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur. J. Immunol. 24: 2317-2322.
46. Bertagnolli, M., and S. Herrmann. 1990. IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity. J. Immunol. 145: 1706-1712.
47. Widmer, M. B., and K. H. Grabstein. 1987. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 326: 795-798.
48. Ye, W., J. D.-E. Young, and C.-C. Liu. 1996. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Cell. Immunol. 174: 54-62.
49. Kienzle, N., K. Buttigieg, P. Groves, T. Kawula, and A. Kelso. 2002. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression. J. Immunol. 168: 1672-1681.
50. Osorio, Y., and H. Ghiasi. 2003. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. J. Virol. 77: 5774-5783.
51. Haak-Frendscho, M., and C. J. Czuprynski. 1992. Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection. Infect. Immun. 60: 1406-1414.
52. Fayad, R., H. Zhang, D. Quinn, Y. Huang, and L. Qiao. 2004. Oral administration with papillomavirus pseudovirus encoding IL-2 fully restores mucosal and systemic immune responses to vaccinations in aged mice. J. Immunol. 173: 2692-2698.
53. Gaffen, S. L., and K. D. Liu. 2004. Overview of interleukin-2 function, production and clinical applications. Cytokine 28: 109-123.
54. Liu, M., B. Acres, J. M. Balloul, N. Bizouarne, S. Paul, P. Slos, and P. Squiban. 2004. Gene-based vaccines and immunotherapeutics. Proc. Natl. Acad. Sci. USA 101: 14567-14571.
55. Tomioka, H. 2004. Adjunctive immunotherapy of mycobacterial infections. Curr. Pharm. Des. 10: 3297-3312.
56. Katlama, C., G. Carcelain, C. Duvivier, C. Chouquet, R. Tubiana, M. De Sa, L. Zagury, V. Calvez, B. Autran, and D. Costagliola. 2002. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study: ANRS 082. AIDS 16: 2027-2034.
57. Farel, C. E., D. G. Chaitt, B. K. Hahn, J. A. Tavel, J. A. Kovacs, M. A. Polis, H. Masur, D. A. Follmann, H. C. Lane, and R. T. Davey, Jr. 2004. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood 103: 3282-3286.
58. Shankar, P., Z. Xu, and J. Lieberman. 1999. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 94: 3084-3093.
59. + T cells in chronic human immunodeficiency virus infection. Blood 96: 3094-3101.